Open access
Jul 2026
Targeting FBXO48 with BC1618 promotes axon regeneration and alleviates symptoms of Parkinson's disease.
These findings highlight that targeting FBXO48 with BC1618 promotes axon regeneration and alleviates symptoms of Parkinson's disease by reducing the degradation of SERBP1, revealing a novel therapeutic target for clinical translation.
Yong-Quan Sun, Pei-Pei Liu, Chang-Ping Li et al.
· Journal of Advanced Research · 0 citations